Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
40%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

NCT05419583
unknownphase_2

Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

NCT05565976
unknown

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

NCT04426084
completedphase_2

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

NCT04301336
completed

Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

NCT03596931

Clinical Trials (5)

Showing 5 of 5 trials
NCT05419583Not Applicable

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

Completed
NCT05565976Phase 2

Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

Unknown
NCT04426084

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

Unknown
NCT04301336Phase 2

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Completed
NCT03596931

Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5